The purpose of this modification is to deobligate $2,863,538.00 from contract HHSO100201500010C. POP ended on 5/21/2024.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSO100201500010C
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$78,310,394.13
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company. The contract has a ceiling value of $78,310,394.13 and a period of performance ending on July 22, 2025.

The purpose of this IDC is to provide a broad range of pharmaceutical products and medical countermeasures to various federal agencies, including influenza vaccines, COVID-19 related products, and specialized treatments. Glaxosmithkline has established itself as a critical supplier to government agencies, delivering vaccines and antiviral medications to the Department of Justice Bureau of Prisons, Department of Veterans Affairs, Centers for Disease Control and Prevention, and the Department of Health and Human Services. The contract vehicle allows for firm fixed-price delivery orders, covering vaccine types such as Fluarix Trivalent and Quadrivalent, as well as antiviral medications like Zanamivir. Additionally, Glaxosmithkline holds multiple significant IDVs and a Federal Supply Schedule contract with federal agencies, demonstrating its extensive capabilities in supporting national immunization efforts and medical supply chains.

Transactions

Action Obligated Date
Other Administrative Action P00033 -$2,863,538
Other Administrative Action P00032 · The purpose of this modification is to transfer 133,835 HHS-owned covid vials ( lot AA03F070C) from contract HHSO100201500010C10C to the covid funded- storage… $0
Other Administrative Action P00031 · This modification will acknowledge the transfer of 1 bulk lot of OWS AS03 (AA03CF070) from clin 0007D contract 02 task order 75A50124F61012 to clin 0005… $0
Other Administrative Action P00030 · This modification will 1. Acknowledge the june 2023 transfer of 1 bulk lot of AS03 (AA03CF183)from contract 02 to contract 10C for fill finish. 2. Authorize GSK… $0
Other Administrative Action P00029 · This modification will transfer 1 bulk lot of AS03 adjuvant lot # AA03CF201, expiration date 4/30/2028, from contract HHSO100201500010C to contract… $0
Other Administrative Action P00028 · This no-cost modification will update the glaxosmithkline, LLC address from 5 moore DR research triangle park, durham, NC 27709 to GSK, LLC 410 blackwell ST,… $0
Other Administrative Action P00027 · The purpose of this no cost modification is to incorporate far clause 52.204-27, prohibition on a bytedance covered application to section i.2 of article i.… $0
Other Administrative Action P00026 · The purpose of this ?no cost? Administrative modification is to update article g.2. Contracting officer's representative(COR). Aminata alharazim replaces arlene… $0
Other Administrative Action P00025 · The purpose of this no-cost modification is to : 1. To transfer AS03 filled adjuvant, AS03 vial ( 10 doses/vial), lot number AA03F152A from HHSO100201500010C to… $0
Other Administrative Action P00024 · The purpose of this modification is to perform an internal administrative change to the clin end date to correspond with the contract period of performance… $0
Other Administrative Action P00023 $0
Other Administrative Action P00022 $0
Other Administrative Action P00021 · The purpose of this no cost modification is to incorporate hhsar clause 352.232-71 - electronic submission of payment requests (FEB 2022), into section i of the… $0
Other Administrative Action P00020 · The purpose of this bilateral modification is to establish clin 0010 to identify the cost associated with the partial termination of this contract. $0
Other Administrative Action P00019 · The purpose of this bilateral modification is to update: section g.3 ? Hhsar 352.237-75, key personnel (december 2015) to remove joanie franke and replace… $0
Other Administrative Action P00018 · The purpose of this modification is to update article g.3 names and positions. The contract administrator has been changed from julie zhao to rhonda berube. $0
Other Administrative Action P00017 · The purpose of this modification is to add clause 52.204-24 ?representation regarding certain telecommunications and video surveillance services or equipment?… $0
Funding Only Action P00016 · The purpose of this modification is to incorporate the following into the contract: - add clin 8.0 to transfer the quality control (QC) test methods used for… $1,175,665
Other Administrative Action P00015 · The purpose of this modification is to make changes within the general scope of the existing contract to amend the statement of work, and accordingly makes… $0
Other Administrative Action 14 $0
Other Administrative Action 13 $0
Other Administrative Action 12 $0
Supplemental Agreement for work within scope 11 $0
Supplemental Agreement for work within scope 10 $0
Other Administrative Action 9 $0
Supplemental Agreement for work within scope 8 $0
Supplemental Agreement for work within scope 7 $0
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Terminate for Convenience 1 $0
Original award $79,998,267
Show all 34

Quick answers

Who was awarded contract HHSO100201500010C?

HHSO100201500010C was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on May 22, 2015.

How much is contract HHSO100201500010C worth?

HHSO100201500010C's own ceiling is $78,310,394.

Who can order from contract HHSO100201500010C?

HHSO100201500010C is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSO100201500010C competed?

The extent of competition for HHSO100201500010C was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login